IdraprilAlternative Names: LG 32001
Latest Information Update: 12 Apr 2000
At a glance
- Originator Guidotti
- Class Antihypertensives; Cyclohexanecarboxylic acids; Hydroxylamines; Small molecules
- Mechanism of Action ACE inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Heart failure; Hypertension; Postmyocardial infarction
Most Recent Events
- 12 Apr 2000 Discontinued-Preclinical for Postmyocardial infarction in Italy (Unknown route)
- 12 Apr 2000 Discontinued-II for Hypertension in Italy (IV)
- 12 Apr 2000 Discontinued-II for Hypertension in Italy (PO)